Effect of in ovo administration of insulin-like growth factor-I on composition and mechanical properties of chicken bone

In ovo applications in poultry: A review,

The various methods employed for the in ovo administration of different materials for promoting the health and productivity of poultry are discussed in this review article. The amnion has proven to be an effective site for injection and the timing of in ovo injection has commonly occurred at transfer. However, the volumes and dosages or concentrations of the materials administered vary depending on bird type, egg size, timing and site of injection, incubation system and regimen, and the type of material. Both manual and automated injections have been shown to be effective. Nevertheless, commercial application mandates automation. Materials described in the literature over the past 20 years or more for in ovo use in avian species include vaccines, drugs, hormones, competitive exclusion cultures and prebiotics, and supplemental nutrients. Vaccines approved for in ovo delivery include those for Marek's disease, infectious bursal disease, fowl pox, Newcastle disease, and coccidiosis. Some of the materials listed above have been shown to be viable candidates for enhancing immunity and for promoting embryonic and posthatch development. Several reports have indicated that probiotics may be effectively used to fight intestinal bacterial infections, and folic aid, as well as egg white protein and various amino acids, including L-arginine, L-lysine, L-histidine, HMB, and threonine alone or in combination, have been shown to benefit embryonic development or posthatch performance. Furthermore, CpG oligodeoxynucleotides, vitamins C and E, and thyme and savory have the potential to enhance immunity, carbohydrates can be used to increase tissue glycogen stores, and creatine can be used to promote muscle growth. Trace minerals and vitamin D3 have shown potential to improve bone strength, and potassium chloride may be an effective alternative electrolyte in vaccine diluent. The in ovo application of these and other materials will continue to expand and provide further benefits to the poultry industry.

In ovo Feeding – Technology of the Future – A Review

Over the years, due to genetic selection, improvement of the characteristics of laying and meat poultry with less feed consumption per kilogram of body weight gain has been achieved (FCR). As the productivity of poultry increased, the demand of embryos for nutrients changed. However, the chemical composition of an egg has remained practically unchanged, and therefore, it began providing the embryos with suitable substances with the help of in ovo technology. Improvements in hatching were achieved through the administration of fructose, sucrose and grape seed extract (GSE), while the weight of a one-day-old chick is affected by the injection of amino acids with glucose and magnesium. In addition, amino acids and carbohydrates applied to an egg have contributed to an increase in the activity of digestive enzymes and maturation of the intestine. In connection with early stimulation of the intestinal tract of broiler chicks, they obtained higher weight gain. Supplementation with vitamins positively affects the increase of birds’ immunity and body weight at the end of breeding. On the other hand, the injection of an insulin-like growth factor (IGF-I) influenced the growth and development of muscle tissue during the first weeks of life.

Physico-chemical properties of late-incubation egg amniotic fluid and a potential in ovo feed supplement

Objective

This study explored the physico-chemical properties of late-incubation egg amniotic fluid and a potential in ovo feed (IOF) supplement.

Methods

Amniotic fluid was collected from broiler breeders (Ross 308, 51 weeks and Cobb 500, 35 weeks) on day 17 after incubation. A mixture of high-quality soy protein supplement – Hamlet Protein AviStart (HPA) was serially diluted in MilliQ water to obtain solutions ranging from 150 to 9.375 mg/mL. The mixtures were heat-treated (0, 30, 60 minutes) in a waterbath (80°C) and then centrifuged to obtain supernatants. The amniotic fluid and HPA supernatants were analysed for their physico-chemical properties.

Results

Only viscosity and K⁺ were significantly (p<0.05) different in both strains. Of all essential amino acids, leucine and lysine were in the highest concentration in both strains. The osmolality, viscosity and pCO₂ of the supernatants decreased (p<0.05) with decreasing HPA concentration. Heat treatment significantly (p<0.05) affected osmolality, pH, and pCO₂, of the supernatants. The interactions between HPA concentration and heat treatment were significant with regards to osmolality (p<0.01), pH (p<0.01), pCO₂ (p<0.05), glucose (p<0.05), lactate (p<0.01) and acid-base status (p<0.01) of HPA solutions. The Ca²⁺, K⁺, glucose, and lactate increased with increasing concentration of HPA solution. The protein content of HPA solutions decreased (p<0.05) with reduced HPA solution concentrations. The supernatant from 150 mg/mL HPA solution was richest in glutamic acid, aspartic acid, arginine and lysine. Amino acids concentrations were reduced (p<0.05) with each serial dilution but increased with longer heating.

Conclusion

The values obtained in the primary solution (highest concentration) are close to the profiles of high-protein ingredients. This supplement, as a solution, hence, may be suitable for use as an IOF supplement and should be tested for this potential.

In ovo leptin administration modulates glucocorticoid receptor mRNA expression specifically in the hypothalamus of broiler chickens

The glucocorticoid receptor (GR) is well documented to play a crucial role in the central control of energy homeostasis in mammals. However, the distribution and function of the GR in the chicken brain are less clear. Leptin is a key hormone regulating energy homeostasis in mammals, yet its action in the chicken is still under debate. In this study, the distribution of GR mRNA in the chicken brain and the effects of in ovo administration of leptin and its antagonist on early post-hatch growth and GR mRNA expression in different hypothalamic nuclei were investigated via in situ hybridization (ISH) and quantitative PCR. GR mRNA was widely expressed in the chicken brain, mainly in the corpus striatum, nucleus rotundus, dorsolateral nucleus, nucleus ovoidalis, nucleus reticularis superior and the hippocampus (Hp) and in the preoptic area of the hypothalamus. High doses of leptin (5.0μg) significantly promoted post-hatch growth, resulting in a significant high body weight increased by 24.64% at day (D) 21 of life. Meanwhile, hypothalamic expression of GR mRNA in the LL and HL groups was down-regulated significantly by 7.02% and 13.65% respectively (P<0.05). ISH revealed region-specific changes: GR mRNA was found to be significantly decreased (P<0.05) in the paraventricular nucleus, periventricular nucleus and ventromedial nucleus but not in the Hp, infundibular nucleus or lateral hypothalamus of D21 broiler chickens. The leptin antagonist was able to reverse the effect of leptin on the growth rate and hypothalamic GR mRNA expression. These results provide evidence that in ovo administration of leptin influences early post-hatch growth and the hypothalamic expression of GR mRNA in broiler chickens.

Synergistic effect of fadrozole and insulin-like growth factor-I on female-to-male sex reversal and body weight of broiler chicks

The aim of this study was to investigate the effects of Fadrozole hydrochloride and recombinant human insulin-like growth factor I (rhIGF-I) on female-to-male sex reversal, hatching traits, and body weight of broiler chickens. On the third day of incubation, fertile eggs were randomly assigned to five experimental groups comprising (i) Fadrozole (0.1 mg/egg), (ii) rhIGF-I (100 ng/egg), (iii) Fadrozole (0.1 mg/egg) + rhIGF-I (100 ng/egg), (iv) vehicle injection (10 mM acetic acid and 0.1% BSA), and (v) non-injected eggs. Eggs in the rhIGF-I-injected groups showed the mode of hatching time at the 480th hour of incubation, 12 hours earlier compared to the other groups, with no statistically significant difference in mortality and hatchability. On Day 1 and 42 of production, 90% of genetically female chicks were masculinized using Fadrozole treatment, while 100% female-to-male phenotypic sex reversal was observed in the Fadrozole+rhIGF-I group. Fadrozole equalized the body weight of both genders, although rhIGF-I was effective on the body weight of male chicks only. Interestingly, combined rhIGF-I and Fadrozole could increase the body weight in both sexes compared to the individual injections (P<0.05). These findings revealed that (i) IGF-I-treated chicken embryos were shown to be an effective option for overcoming the very long chicken deprivation period, (ii) the simultaneous treatment with Fadrozole and IGF-I could maximize the female-to-male sex reversal chance, (iii) the increase in the body weight of masculinized chickens via Fadrozole could be equal to their genetically male counterparts, and (iv) the IGF-I effectiveness, specifically along with the application of aromatase inhibitors in female chicks, indicates that estrogen synthesis could be a stumbling block for the IGF-I action mechanism in female embryos.

Prospects of in ovo feeding and nutrient supplementation for poultry: the science and commercial applications--a review

In ovo supplementation of poultry embryos was first reported several decades ago, but it is only recently that concerted research has been directed at developing the technology for this process to be routinely used by the poultry industry. Although the technology of in ovo feeding was patented more than 10 years ago, it has not been widely adopted by the poultry industry. This review examines the early development of the enteric system of the poultry embryo; defines and distinguishes between in ovo feeding and in ovo nutrient administration; highlights the importance of early feeding of the chick; and discusses the development of in ovo feeding technology and its effects on hatchability, growth, gut health and immune response of chicks. The range of possible nutrients that can be administered is also explored. The limitations associated with embryo development and nutrient metabolism are highlighted, leading to the prediction of the future role of in ovo feeding in the poultry industry.

Effects of dietary energy and calcium levels on performance, egg shell quality and bone metabolism in hens

This study investigated the effects of dietary energy and calcium levels on laying performance, eggshell quality and bone metabolism of layers. One hundred and sixty-two 19-week-old Hy-Line brown laying hens in 54 battery cages were allocated to one of nine dietary treatments with control, middle and high levels of energy (11.50, 12.68 and 13.37 MJ/kg, respectively) and low, control and high levels of calcium (2.62%, 3.7% and 4.4%, respectively) for 60 days, using a 3 × 3 factorial arrangement. Compared with the control energy diet, high- and middle-energy diets increased fat deposition and egg weight, decreased feed intake and bone quality and had no effects on eggshell quality. The high-energy diet reduced the serum phosphate concentration and elevated osteocalcin mRNA expression in the keel bone without increasing osteocalcin protein. Dietary calcium intake did not affect fat deposition, feed intake or egg weight. Low dietary calcium resulted in weaker eggshells and poorer bone quality than that from hens fed the control diet. High dietary calcium increased serum calcium concentration, osteoprotegerin mRNA and osteocalcin protein and inhibited serum alkaline phosphatase activity and decreased its mRNA compared with low or control dietary calcium. The high-energy and high-calcium diet significantly reduced egg production. Compared with the control energy diet, high- and middle-energy diets increased fat deposition but had negative effects on bone metabolic homeostasis. Dietary calcium did not influence fat deposition but a high-calcium diet benefited bone homeostasis, while a low-calcium diet was associated with poorer eggshell quality and bone homeostasis.

In ovo administration of rhIGF-1 to duck eggs affects the expression of myogenic transcription factors and muscle mass during late embryo development

In ovo administration of IGF-1 to poultry eggs has effective roles on post hatching muscle development. However, the secondary muscle development stages at the late embryo development stage are important for muscle fiber formation and differentiation. To investigate the roles of in ovo administration of IGF-1 on duck secondary muscle development, we injected rhIGF-1 into duck eggs in hatching at day 12. After administration on days 18, 21, 24, and 27 in hatching (E18d, E21d, E24d, and E27d, respectively), muscle samples were isolated, and the muscle tissue weight, muscle fiber parameters, and myoblast proliferation rate in leg and breast muscle were analyzed. Additionally, the expression levels of the transcription factors MyoG and MRF4 were detected using qPCR. Results show that embryo body weight and muscle fiber parameters, including muscle fiber diameter (MFD) and the number of myofibers per unit area, are upregulated in IGF-1-treated groups. Moreover, the transcription factors MyoG and MRF4 are expressed at higher levels in the experimental groups compared with the control groups. These results suggest that in ovo administration of IGF-1 to poultry eggs can mediate the expression of MyoG and MRF4, induce myoblast proliferation, and finally influence muscle development during the secondary muscle development stages.

Effects of commercial in ovo injection of carbohydrates on broiler embryogenesis

The effects of in ovo injection of different carbohydrate solutions on hatchability of fertilized eggs (HF), rate of hatch, BW, body moisture, yolk sac weight, and yolk sac moisture of Ross × 708 broiler chicks, hatched from eggs laid by a 34-wk-old breeder flock, were investigated. Eggs containing live embryos were injected, using an automated multiple-egg injector, in the amnion on d 18.5 of incubation with 0.1, 0.4, 0.7, or 1.0 mL of commercial diluent or a carbohydrate dissolved in diluent. The commercial diluent containing 0.25 g/mL of one of the following carbohydrates was injected into eggs: glucose, fructose, sucrose, maltose, or dextrin. The results showed that no carbohydrate type or solution volume affected rate of hatch. Absolute and proportional BW on day of hatch were positively related to injection volume (P < 0.001). However, HF was negatively related to injection volume (P < 0.001). To realize an HF of 90%, the injection volume could not exceed 0.4 mL for fructose or sucrose and could not exceed 0.7 mL for glucose, maltose, or dextrin. Yolk-free BW was negatively related to injection volume of fructose and sucrose (P < 0.004), but was not related to injection volume of diluent, glucose, maltose, and dextrin. Conversely, absolute and proportional yolk sac weights were positively related to injection volume of fructose, sucrose, and dextrin (P < 0.01), but were also not significantly related to injection volume of diluent, glucose, and maltose. Yolk sac moisture was positively related to injection volume for all injectables, including the diluent (P < 0.03). However, body moisture and yolk-free body moisture were not related to injection type or volume. In conclusion, the use of carbohydrates added to a commercial diluent for the in ovo injection of broiler hatching eggs requires the use of appropriate volumes to promote growth and nutrient utilization without adversely affecting HF.

Insulin-like growth factor-I gene polymorphism associations with growth, body composition, skeleton integrity, and metabolic traits in chickens

Molecular genetic selection on individual genes is a promising method to genetically improve economically important traits in chickens. A resource population was developed to study the genetics of growth, body composition, skeletal integrity, and metabolism traits. Broiler sires were crossed to dams of 2 diverse, highly inbred lines (Leghorn and Fayoumi), and the F1 birds were intermated by dam line to produce broiler-Leghorn and broiler-Fayoumi F2 offspring. Growth, body composition, skeletal integrity, and hormonal and metabolic factors were measured in 713 F2 individuals. Insulin-like growth factor-I (IGF1) was selected for study as a biological and positional candidate gene. A single nucleotide polymorphism (SNP) was identified between the founder lines in the IGF1 promoter region, and a PCR-RFLP assay was developed. A mixed model was used to statistically analyze associations of IGF1-SNP1 with phenotypic traits. The IGF1-SNP1 had significant associations with most recorded traits, except metabolic traits. Strong interactions between the IGF1 gene and genetic background on growth traits in the 2 F2 populations suggest that genetic interaction is an important aspect for consideration before using the IGF1-SNP1 in marker-assisted selection programs. Several beneficial effects (improved growth, increased breast muscle weight, decreased abdominal fat, and enhanced skeletal integrity) associated with 1 allele indicate the presence of 1 or more loci near IGF1-SNP1 controlling biologically diverse and economically important traits in chickens.

Effect of embryonic photostimulation on the posthatch growth of turkey poults

Artificial illumination, including light quality, is important in modern meat-type poultry management. In the present study, the effect of in ovo monochromatic green light photostimulation on posthatch growth of turkey poults was investigated. In experiment 1, 182 turkey eggs were divided into two light treatment groups (n = 91). The first group was intermittently photostimulated (3 min on and 3 min off) with green light provided by five light-emitting diodes (LED) per egg at 0.1 W/m2 at the upper eggshell surface. The second group was incubated in the dark and served as the control. Posthatch BW were recorded at 0, 2, 6, 13, 20, 28, 35, and 59 d of age. A heavier BW, occurring at 28 d of age and persisting until the end of the experiment (59 d of age), was observed in the in ovo green light stimulated females as compared to their corresponding controls. In experiment 2, 273 turkey eggs were divided into three light treatment groups (n = 91). The first group was intermittently photostimulated (15 min on and 15 min off) with green light provided by seven LED per egg at 0.14 W/m2. The second group was photostimulated with white light provided by one mini-incandescent lamp per egg at light intensity and schedule similar to the first group. Eggs of the third group were incubated in the dark and served as controls. Posthatch BW were recorded at 0, 7, 14, 28, 42, 56, and 79 d of age. No differences were found among the BW of males incubated under different light conditions. As in experiment 1, female turkeys with stimulated green light in ovo had greater BW compared to their corresponding control and white light groups from 28 d of age until termination of the experiment at 79 d of age. Breast muscle weight was greater in female turkeys incubated under green light when compared to white and dark incubation treatment groups. We suggest that in ovo green light photostimulation enhances the posthatch BW of female turkey poults.